Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?

Moderna Today MRNA Moderna $90.28 +3.44 (+3.96$62.55 ▼ $170.47 Price Target$124.07 Add to Watchlist Biotechnology company Moderna Inc. NASDAQ: MRNA stock rocked investors with a 30% drop following its second-quarter 2024 earnings release. The company disappointed investors when it revised its respiratory franchise revenue forecast lower by half a billion dollars. However, shares were able to bounce off their low of $78.07 and start to climb back. While COVID is no longer a pandemic, it is ...